Search Results 251-260 of 16845 for Linaclotide

  1. A Study of DCC-2618 vs. Sunitinib in Advanced GIST Patients after Treatment with Imatinib - Mayo Clinic

    Approximately 358 patients will be randomized in a 1:1 ratio to DCC-2618 150 mg once daily (QD) (continuous dosing for 6 week cycles) or sunitinib 50 mg QD (6 ...

  2. Galcanezumab-gnlm (subcutaneous route) - Side effects & dosage - Mayo Clinic

    Galcanezumab-gnlm injection is used to prevent migraine headaches. It is also used to treat cluster headache, a form of headache that produces extreme pain and ...

  3. A Study of Nab-Paclitaxel as Maintenance Treatment After Cisplatin-Based Chemotherapy and Surgery for Patients with High-Risk Bladder Cancer - Mayo Clinic

    Maintenance therapy, such as paclitaxel albumin-stabilized nanoparticle formulation, can help keep cancer from coming back after it has disappeared following ...

  4. Clinical trials - Oncology (Medical)

    The purpose of this study is to compare the effect of adding nivolumab to the usual chemotherapy (cisplatin or carboplatin with gemcitabine) versus the ...

  5. Clinical trials - Oncology (Medical)

    The purpose of this study is to compare the effectiveness of axicabtagene ciloleucel versus standard of care therapy (SOCT), as measured by eventfree ...

  6. Aclidinium and formoterol (inhalation route) - Side effects & dosage - Mayo Clinic

    Aclidinium and formoterol combination is used as maintenance treatment in patients with chronic obstructive pulmonary disease (COPD). It will not relieve a COPD ...

  7. Clinical trials - Oncology (Medical)

    The purpose of this study is to find out if tucatinib with other cancer drugs works better than standard of care to treat participants with HER2 positive ...

  8. Publications - Layne M. Bettini, M.D., J.D. - Mayo Clinic

    Pai SL, Nimma SR, Beam WB, VanderWielen BA, Kalagara HK, Bettini LM, Yu S, Sharpe EE, Harbell MW. Assessment of Gastric Content Using Gastric Ultrasound in ...

  9. Fosnetupitant/palonosetron (intravenous route) - Side effects & uses - Mayo Clinic

    Fosnetupitant and palonosetron combination injection is used together with dexamethasone to prevent nausea and vomiting that is caused by cancer medicines ( ...

  10. Safety and Efficacy of a Lysophosphatidic Acid Receptor Antagonist in Idiopathic Pulmonary Fibrosis - Mayo Clinic

    The purpose of this study is to determine if study drug (BMS-986020) dose of 600 mg once daily or 600 mg twice daily for 26 weeks compared with placebo will ...